Overview

Analgesic Effect of Pregabalin in Patients Undergoing Total Abdominal Hysterectomy

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Pregabalin will decrease the total amount of opioid required in patients undergoing total abdominal hysterectomy. In addition, pregabalin will decrease the incidence of opioid-related side effects in patients undergoing total abdominal hysterectomy.
Phase:
N/A
Details
Lead Sponsor:
Northwestern University
Treatments:
Analgesics
Pregabalin